Based on your height and weight, your body mass index (BMI) is about 35.5 kg/m², which falls in the obesity range. Mounjaro (tirzepatide) has been shown to help some adults with obesity lose significant weight when prescribed by a doctor and combined with a reduced‑calorie diet and regular physical activity. Whether it is safe and suitable for you depends on your medical history, any underlying health conditions, current medications, and possible contraindications. It can cause side effects such as nausea, vomiting, diarrhoea, constipation, and reduced appetite, and it is not appropriate for everyone. The safest step is to consult your doctor or an obesity medicine specialist, who can assess your health and advise you on whether Mounjaro is the right option, including the appropriate dose and monitoring.

Mounjaro 2.5mg Solution for Injection 0.5 ml is available in both vial and prefilled KwikPen forms. The vial version does not include an injection device. It requires separate administration equipment, while the KwikPen version is designed for self-administration and includes a built-in injector mechanism.

Type 2 diabetes can be managed with regular meal timing, balanced food choices, and diet control. Avoid sugary drinks and refined foods, and stay physically active most days of the week. Monitor your blood sugar regularly and take medicines as prescribed. Maintain healthy sleep, manage stress, and attend routine medical reviews to prevent complications.

Your eligibility for Mounjaro 2.5 mg Solution for Injection (Tirzepatide) depends on your specific health condition. It is primarily prescribed for adults with type 2 diabetes to help control blood sugar. Your doctor will review your medical history, current medications, and kidney and liver function to determine if it is suitable for you.

Based on the information provided, your BMI falls in the obesity range. In adults with obesity, prescription weight-loss therapies may be considered when lifestyle measures alone have not been effective. However, starting such treatment requires a thorough medical evaluation, including assessment of your overall health, medical history, and potential risks. A consultation with a qualified physician or endocrinologist is essential to determine whether this type of therapy is appropriate and safe for you, and to ensure it is used under proper medical supervision.

Mounjaro (tirzepatide) is typically administered once weekly, regardless of whether the 2.5 mg or 5 mg solution is used. Your doctor determines the dosage and duration of treatment based on your individual health needs, treatment goals, and response to therapy. Always follow your doctor’s instructions carefully and do not adjust the dose or timing without medical guidance.